These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22926178)

  • 21. Recommendations for treatment of intermittent mild persistent asthma in children and adolescents.
    Naspitz CK; Cropp GJ
    Pediatr Pulmonol; 2009 Mar; 44(3):205-8. PubMed ID: 19206182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of exacerbation of asthma: what are today's issues?].
    Ploin D; Rousson A; Vitoux-Brot C; Nouyrigat V; Foucaud P; Lemaire JP; Chevallier B; Bergeron S; Martinot A; Chéron G; Floret D
    Arch Pediatr; 2005 Mar; 12(3):351-6. PubMed ID: 15734138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long-acting beta 2-agonists in addition to inhaled corticosteroids in children and adults with chronic asthma. A survey of two Cochrane reviews].
    Ulrik CS
    Ugeskr Laeger; 2007 Mar; 169(11):997-1001. PubMed ID: 17371632
    [No Abstract]   [Full Text] [Related]  

  • 24. Asthma pharmacotherapy.
    Schofield ML
    Otolaryngol Clin North Am; 2014 Feb; 47(1):55-64. PubMed ID: 24286679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Investigation of optimal drug in moderate bronchial asthma].
    Kataoka A; Nishimura N; Uchiyama N; Ono H; Kishi J; Chonabayashi N
    Arerugi; 2007 Jul; 56(7):685-90. PubMed ID: 17671411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma'].
    Diamant Z; Dekhuijzen PN
    Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1681-5. PubMed ID: 14513539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controversies involving inhaled beta-agonists and inhaled corticosteroids in the treatment of asthma.
    Fahy JV; Boushey HA
    Clin Chest Med; 1995 Dec; 16(4):715-33. PubMed ID: 8565410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of asthma in resource-limited settings: role of low-cost corticosteroid/β-agonist combination inhaler.
    Chiang CY; Aït-Khaled N; Bissell K; Enarson DA
    Int J Tuberc Lung Dis; 2015 Feb; 19(2):129-36. PubMed ID: 25574908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose inhaled corticosteroid use in childhood asthma: an observational study of GP prescribing.
    Thomas M; Turner S; Leather D; Price D
    Br J Gen Pract; 2006 Oct; 56(531):788-90. PubMed ID: 17007710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
    Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
    Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological management of children's asthma in general practice: findings from a community-based cross-sectional survey in Auckland, New Zealand.
    Crengle S; Robinson E; Grant C; Arroll B
    N Z Med J; 2011 Nov; 124(1346):44-56. PubMed ID: 22143852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting small airways in asthma: improvement in clinical benefit?
    Ulrik CS; Lange P
    Clin Respir J; 2011 Jul; 5(3):125-30. PubMed ID: 21106032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolerability profiles of leukotriene receptor antagonists and long-acting beta2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma: a review.
    Colucci R; Fornai M; Tuccori M; Antonioli L; Pasqualetti G; Blandizzi C; Del Tacca M
    J Asthma; 2007; 44(6):411-22. PubMed ID: 17654125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An official American Thoracic Society clinical practice guideline: exercise-induced bronchoconstriction.
    Parsons JP; Hallstrand TS; Mastronarde JG; Kaminsky DA; Rundell KW; Hull JH; Storms WW; Weiler JM; Cheek FM; Wilson KC; Anderson SD;
    Am J Respir Crit Care Med; 2013 May; 187(9):1016-27. PubMed ID: 23634861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The gap between evidence-based medicine and daily practice in the management of paediatric asthma. A pharmacy-based population study from The Netherlands.
    de Vries TW; Tobi H; Schirm E; van den Berg P; Duiverman EJ; de Jong-van den Berg LT
    Eur J Clin Pharmacol; 2006 Jan; 62(1):51-5. PubMed ID: 16365748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update in paediatric asthma management: where is evidence challenging current practice?
    Robinson PD; Van Asperen P
    J Paediatr Child Health; 2013 May; 49(5):346-52. PubMed ID: 21470328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Childhood asthma: Danish guidelines for diagnosis and treatment].
    Bønnelykke K; Pedersen S; Rubak SL; Schiøtz O; Bisgaard H
    Ugeskr Laeger; 2013 Aug; 175(33):1863-7. PubMed ID: 23937873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The right tools at the right time.
    Humbert M
    Chest; 2006 Jul; 130(1 Suppl):29S-40S. PubMed ID: 16840366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disagreement between guidelines regarding the third step of asthma drug therapy for school-age children.
    Miceli Sopo S; Bersani G; Del Vescovo E; Gelsomino M
    Allergol Immunopathol (Madr); 2020; 48(6):789-791. PubMed ID: 32371029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Weighing the risks of treatment versus nontreatment in pediatric asthma.
    Spahn JD; Covar RA
    Pediatr Clin North Am; 2003 Jun; 50(3):677-95. PubMed ID: 12877241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.